Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Imv Inc (NQ: IMV )

0.5418 +0.0192 (+3.67%)
Streaming Delayed Price Updated: 3:54 PM EDT, Mar 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,489
Open 0.5315
Bid (Size) 0.5305 (2)
Ask (Size) 0.5499 (13)
Prev. Close 0.5226
Today's Range 0.5231 - 0.5499
52wk Range 0.4900 - 15.30
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results
From IMV Inc.
Via Business Wire
Earnings Scheduled For March 15, 2023
Companies Reporting Before The Bell • Sportradar Gr (NASDAQ:SRAD) is estimated to report quarterly earnings at $0.04 per share on revenue of $208.09 million. 
Via Benzinga

Performance

YTD
-77.52%
-77.52%
1 Month
-38.79%
-38.79%
3 Month
-78.67%
-78.67%
6 Month
-90.55%
-90.55%
1 Year
-96.24%
-96.24%

More News

Read More
IMV's Earnings: A Preview
Via Benzinga
IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023
From IMV Inc.
Via Business Wire
Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why IMV Stock Is Getting Hammered
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
IMV Stock Falls After Interim Data From Lead Candidate In Blood Cancer Subtype
Via Benzinga
IMV Inc. Presents Positive Initial Results From The MVP-S Phase 2B VITALIZE Trial
From IMV Inc.
Via Business Wire
IMV Inc. Announces Update and Planned 2023 Milestones to Advance Clinical Development of its Lead Therapeutic, MVP-S
From IMV Inc.
Via Business Wire
Why Core Scientific Shares Are Trading Lower By Around 32%; Here Are 26 Stocks Moving Premarket
Via Benzinga
IMV Announces Closing of US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From IMV Inc.
Via Business Wire
Why Avaya Holdings Shares Are Trading Lower By 62%? Here Are 62 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
IMV Announces US$9 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
From IMV Inc.
Via Business Wire
Dow Dips Over 800 Points; S&P 500 Down 2.8%
Via Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Nasdaq Drops Over 300 Points; Crude Oil Down 1.5%
Via Benzinga
Dow Tumbles Over 500 Points; ECB Raises Rates By 50 bps
Via Benzinga
IMV Inc. Announces Initial Data from the Ongoing Phase 2B VITALIZE Trial in Patients with r/r DLBCL
From IMV Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
IMV Commences Trading on the TSX and Nasdaq Post-Reverse Stock Split
From IMV Inc.
Via Business Wire
IMV Shareholders Approve Reverse Stock Split at 88%
From IMV Inc.
Via Business Wire
IMV Receives Nasdaq Notification Regarding Market Value of Listed Securities
From IMV Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.